Vitamin D for COVID-19: a case to answer? - September 2020
- Funded by UK Research and Innovation (UKRI)
- Total publications:0 publications
Grant number: C19-IUC-506
Grant search
Key facts
Disease
COVID-19Funder
UK Research and Innovation (UKRI)Principal Investigator
Prof. Nita ForouhiResearch Location
United KingdomLead Research Institution
MRC Epidemiology UnitResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Supportive care, processes of care and management
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
In a comment article in the Lancet Diabetes & Endocrinology, Unit scientist Professor Nita Forouhi and Professor Adrian Martineau of the Blizard Institute discuss the available evidence for a role for Vitamin D in preventing or treating COVID -19 infection. They note that current evidence is inconclusive and recommend population-based trials investigating vitamin D supplementation as a means of reducing the severity of COVID-19. In meantime they urge measures to ensure that people achieve recommended daily amounts of Vitamin D (10 micrograms per day for adults in the UK) saying this "might also reduce the impact of COVID-19 in populations where vitamin D deficiency is prevalent; there is nothing to lose from their implementation, and potentially much to gain."